News

Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings

Provides Additional Working Capital to Further Fund Growth Initiatives SILVER SPRING, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (the “Company”), a commercial-stage regenerative medicine company announced today that it has entered into a $25 million credit facility...

Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO

SILVER SPRING, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced Aziyo co-founder C....

Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen

Call to Highlight the Use and Benefits of Aziyo’s CanGaroo Envelope for Implantable Electronic Devices SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...

Displaying 1 - 10 of 15